I want to be precise about terminology here: semaglutide does not cause pharmacological withdrawal in the way that benzodiazepines, opioids, or SSRIs do. There is no physical dependence mechanism. You will not have seizures, serotonin syndrome, or anything dangerous from stopping.
However, what you're experiencing is very real and I'd describe it as rebound physiology rather than withdrawal. Your body has adapted to 16 months of GLP-1 receptor agonism, and removing that signal causes measurable changes:
- Appetite rebound: This is the biggest one. GLP-1 RAs suppress appetite through hypothalamic signaling and delayed gastric emptying. When the drug clears (~5 weeks for semaglutide given its 7-day half-life), gastric emptying normalizes and appetite signaling ramps back up. Many patients describe this as "the food noise coming back" and it can feel overwhelming.
- Blood glucose fluctuations: If you had any degree of insulin resistance, glucose control may temporarily worsen. This can cause irritability, headaches, and fatigue.
- GI adjustment: Your GI tract has adapted to slower motility. Normalization can cause temporary changes in bowel habits — some people get diarrhea, others get acid reflux as gastric emptying speeds back up.
- Mood changes: There's increasing recognition that GLP-1 RAs have effects on brain reward circuitry. Emerging research suggests they modulate dopaminergic signaling. Removing that modulation can affect mood and motivation.[1]
The anxiety and irritability you're describing at 5 days out is consistent with this timeline.
As for tapering: there's no FDA-approved taper protocol for semaglutide discontinuation. However, some clinicians (myself included) prefer a gradual step-down rather than abrupt cessation when possible. For example: 2mg → 1mg for 4 weeks → 0.5mg for 4 weeks → 0.25mg for 4 weeks → stop. This gives the body more time to readjust.
Since your coverage ends April 1st, you might not have time for a full taper. But even one month at a lower dose could help.